4.7 Review

Reverse genetics technology for Rift Valley fever virus: Current and future applications for the development of therapeutics and vaccines

期刊

ANTIVIRAL RESEARCH
卷 84, 期 2, 页码 101-118

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2009.08.002

关键词

Vaccine; Rift Valley fever virus; Non-structural protein; Bunyavirus; Phlebovirus; Reverse genetics; cDNA clone; Infectious clone; Minigenome rescue; Virus-like particle; Attenuation

资金

  1. NIAID NIH HHS [U01 AI066327-04] Funding Source: Medline

向作者/读者索取更多资源

The advent of reverse genetics technology has revolutionized the study of RNA viruses, making it possible to manipulate their genomes and evaluate the effects of these changes on their biology and pathogenesis. The fundamental insights gleaned from reverse genetics-based studies over the last several years provide a new momentum for the development of designed therapies for the control and prevention of these viral pathogens. This review summarizes the successes and stumbling blocks in the development of reverse genetics technologies for Rift Valley fever virus and their application to the further dissection of its pathogenesis and the design of new therapeutics and safe and effective vaccines. (C) 2009 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据